VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report)’s share price traded up 11.8% on Thursday . The stock traded as high as C$0.20 and last traded at C$0.19. 312,200 shares changed hands during mid-day trading, an increase of 241% from the average session volume of 91,579 shares. The stock had previously closed at C$0.17.
VentriPoint Diagnostics Stock Performance
The firm’s 50-day moving average price is C$0.18 and its two-hundred day moving average price is C$0.21. The company has a quick ratio of 6.67, a current ratio of 0.28 and a debt-to-equity ratio of 217.41. The firm has a market capitalization of C$29.86 million, a PE ratio of -6.33 and a beta of 0.41.
VentriPoint Diagnostics Company Profile
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.
Recommended Stories
- Five stocks we like better than VentriPoint Diagnostics
- Trading Stocks: RSI and Why it’s Useful
- When Is the Best Time to Invest in Mutual Funds?
- What is the Nikkei 225 index?
- Is NVIDIA Stock in a Correction or Consolidation?
- How to buy stock: A step-by-step guide for beginners
- 3 Oversold Stocks with Big RSI Rebound Potential
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
